Your browser doesn't support javascript.
loading
The type II secretion system as an underappreciated and understudied mediator of interbacterial antagonism.
Cianciotto, Nicholas P.
Affiliation
  • Cianciotto NP; Department of Microbiology-Immunology, Northwestern University School of Medicine , Chicago, Illinois, USA.
Infect Immun ; 92(8): e0020724, 2024 Aug 13.
Article in En | MEDLINE | ID: mdl-38980047
ABSTRACT
Interbacterial antagonism involves all major phyla, occurs across the full range of ecological niches, and has great significance for the environment, clinical arena, and agricultural and industrial sectors. Though the earliest insight into interbacterial antagonism traces back to the discovery of antibiotics, a paradigm shift happened when it was learned that protein secretion systems (e.g., types VI and IV secretion systems) deliver toxic "effectors" against competitors. However, a link between interbacterial antagonism and the Gram-negative type II secretion system (T2SS), which exists in many pathogens and environmental species, is not evident in prior reviews on bacterial competition or T2SS function. A current examination of the literature revealed four examples of a T2SS or one of its known substrates having a bactericidal activity against a Gram-positive target or another Gram-negative. When further studied, the T2SS effectors proved to be peptidases that target the peptidoglycan of the competitor. There are also reports of various bacteriolytic enzymes occurring in the culture supernatants of some other Gram-negative species, and a link between these bactericidal activities and T2SS is suggested. Thus, a T2SS can be a mediator of interbacterial antagonism, and it is possible that many T2SSs have antibacterial outputs. Yet, at present, the T2SS remains relatively understudied for its role in interbacterial competition. Arguably, there is a need to analyze the T2SSs of a broader range of species for their role in interbacterial antagonism. Such investigation offers, among other things, a possible pathway toward developing new antimicrobials for treating disease.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Type II Secretion Systems Limits: Humans Language: En Journal: Infect Immun Year: 2024 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Type II Secretion Systems Limits: Humans Language: En Journal: Infect Immun Year: 2024 Type: Article Affiliation country: United States